Question 1

Berapa harga saham Pfizer hari ini?

Accepted Answer

Harga semasa Pfizer ialah 26.27 USD — ia telah meningkat sebanyak 1.55% dalam 24 jam yang lepas. Lihat prestasi harga saham Pfizer dengan lebih teliti pada grafik lanjutan.

Question 2

Apakah simbol saham Pfizer?

Accepted Answer

Bergantung pada bursa, simbol saham mungkin berbeza. Sebagai contoh, di bursa NYSE, saham Pfizer diniagakan dengan simbol PFE.

Question 3

Adakah harga saham PFE sedang naik?

Accepted Answer

Saham PFE telah meningkat sebanyak 2.90% dalam minggu lepas, telah menurun sebanyak -0.32% dalam bulan lepas, dan telah menurun sebanyak -5.06% dalam tahun lepas. Lihat lebih banyak data pada grafik PFE.

Question 4

Apakah cadangan penganalisis untuk PFE?

Accepted Answer

Setakat 22 Feb 2025, daripada 13 cadangan penganalisis, majoriti memberi penarafan PFE sebagai hold.

Question 5

Apakah nilai pasaran PFE?

Accepted Answer

Setakat hari ini, PFE mempunyai kapitalisasi pasaran sebanyak 146.78B USD. Jelajahi senarai saham kami yang diatur mengikut kapitalisasi pasaran untuk membandingkan PFE dengan saham lain.

Question 6

Adakah PFE mengeluarkan laporan kewangan?

Accepted Answer

Ya, anda boleh menjejaki kewangan PFE dalam laporan tahunan dan suku tahunan di Profit.com.

Question 7

Bila tarikh laporan pendapatan seterusnya PFE?

Accepted Answer

PFE akan mengeluarkan laporan pendapatan seterusnya pada 29 Apr 2025. Jejak acara yang akan datang dengan Kalendar Pendapatan kami.

Question 8

Berapa pendapatan PFE untuk suku tahunan lepas?

Accepted Answer

PFE melaporkan pendapatan sebanyak $1.06 setiap saham untuk suku tahunan lepas, lebih tinggi daripada anggaran $0.62 setiap saham, menghasilkan kejutan 70.97%. Pendapatan yang dianggarkan untuk suku tahunan akan datang adalah $0.49 setiap saham. Lihat butiran lanjut tentang pendapatan PFE di Profit.com.

Question 9

Berapa hasil PFE untuk suku tahunan lepas?

Accepted Answer

Hasil PFE untuk suku tahunan lepas ialah 17.76B USD, lebih tinggi daripada anggaran 13.54B USD. Hasil yang dianggarkan untuk suku tahunan akan datang ialah 15.75B USD. Lihat lebih banyak statistik dalam laporan kewangan PFE di Profit.com.

Question 10

Berapa Pendapatan Bersih PFE untuk suku tahunan lepas?

Accepted Answer

Pendapatan bersih PFE untuk suku tahunan lepas adalah 410M USD, manakala suku tahunan sebelumnya menunjukkan pendapatan bersih sebanyak 4.46B USD, yang mencatatkan perubahan sebanyak -90.82%. Lihat lebih banyak statistik dalam laporan kewangan PFE di Profit.com.

Question 11

Adakah PFE membayar dividen?

Accepted Answer

Ya, dividen PFE dibayar setiap suku tahun. Dividen terakhir per saham ialah 1.68. Sehingga hari ini, Dividend Yield (TTM)% adalah 6.54%.

Question 12

Berapa ramai pekerja yang ada di PFE?

Accepted Answer

Sehingga 22 Feb 2025, PFE menggaji kira-kira - pekerja. Lihat jika PFE berada dalam senarai majikan terbesar kami.

Question 13

Apakah EBITDA PFE?

Accepted Answer

EBITDA, yang mengukur prestasi operasi syarikat, mencerminkan peningkatan kecekapan. EBITDA PFE ialah 23.27B USD, dengan margin EBITDA semasa sebanyak 12.62%. Lihat lebih banyak statistik dalam laporan kewangan PFE di Profit.com.

Question 14

Bagaimana untuk membeli saham PFE?

Accepted Answer

Seperti saham lain, saham PFE diperdagangkan di bursa saham seperti NYSE. Cara paling mudah untuk membelinya adalah melalui broker saham dalam talian. Buka akaun, ikuti prosedur broker, dan mula berdagang. Sebagai alternatif, anda boleh berlatih berdagang saham Tesla di Profit.com dalam Playtrade Tournaments atau pilih broker yang disyorkan untuk berdagang terus.

Question 15

Patutkah saya melabur dalam saham PFE?

Accepted Answer

Melabur dalam saham memerlukan penyelidikan yang teliti, termasuk menganalisis kewangan syarikat, berita berkaitan, dan analisis teknikal. Pada masa ini, cadangan penganalisis teknikal Tesla menunjukkan penarafan hold.

Sebelum melabur dalam PFE, pertimbangkan untuk melanggan Profit PRO di mana anda boleh berlatih berdagang dalam Playtrade Tournaments, mengakses pandangan pasaran harian yang digerakkan oleh AI, menyalin Watchlists yang dipilih dengan teliti, dan mengikuti Portfolia Bilionaire.

Pfizer Inc

Pfizer stock climbs on Q4 revenue and earnings beat, reaffirmed guidance

Sangamo Therapeutics’ stock falls the most in 16 years after Pfizer ends Hemophilia pact

Pfizer names oncology chief and company veteran Boshoff as chief scientific officer

Vaccine-maker stocks like Moderna, Pfizer drop as Trump picks RFK Jr. to lead HHS

Pfizer CEO says he welcomes good ideas as Starboard ups pressure on company

Pfizer tops earnings estimates, hikes full-year guidance as Covid products help sales - CNBC

FDA approves Pfizer's RSV vaccine for adults at increased risk of the disease - CNBC

Pfizer wins FDA approval for hemophilia B drug that will be first once-weekly treatment

Pfizer former executives exit activist drive (NYSE:PFE) - Seeking Alpha

Pfizer threatened to sue renegade executives prior to activist schism, Starboard's Smith says - CNBC

Former Pfizer CEO, finance chief step back from Starboard's activist campaign - CNBC

Pfizer wins bid to invalidate GSK's patents over RSV vaccine https://t.co/U4qDo7fLwQ https://t.co/1oT7s25ePe

Activist investor Starboard has informed Pfizer it has taken a stake - Business Insider

Starboard reportedly takes $1 billion stake in Pfizer, seeks changes

Activist Starboard Value has $1 billion Pfizer stake, taps former executives for help, sources say - CNBC

Activist Starboard takes $1B stake in Pfizer - WSJ

Exclusive | Activist Starboard Value Takes $1 Billion Stake in Pfizer - The Wall Street Journal

Pfizer yanks sickle-cell treatment worldwide after possible link to deaths

Pfizer says its experimental drug for deadly condition that causes appetite and weight loss in cancer patients shows positive trial results - CNBC

Pfizer and Valneva report positive results in mid-stage trial of Lyme disease vaccine

Pfizer-BioNTech’s COVID-19-and-flu combination drug meets 1 of 2 trial objectives

Pfizer reports positive results in study of vaccine for immunocompromised adults at risk of severe RSV-related illness

UK regulator authorises updated Pfizer-BioNTech COVID shot targeting JN.1 strain https://t.co/p57xSfPA5r https://t.co/duJDOW0QcD

Pfizer announces positive results from late-stage trial of hemophilia A treatment

Pfizer signals progress on obesity pill, boosting stock

Pfizer moves forward with once-daily version of weight loss pill after setbacks

SEC blasts Pfizer's bid for $75 million from insider trading victims' fund https://t.co/zi2o5UQjRt https://t.co/oqYMmcJzfN

Pfizer defends appellate court’s ‘naming names’ rule in lawsuit over diversity program https://t.co/AJ35cUGXng https://t.co/0EpfCJjqze

UK court gives mixed ruling in Pfizer v Moderna COVID vaccine patents case https://t.co/eCV2WLo1sb https://t.co/ant6wAXYMX

Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline - CNBC

Alnylam’s stock surges as heart drug vies with a Pfizer blockbuster

Pfizer's Duchenne gene therapy fails in late-stage study https://t.co/z9hCGWBuFv https://t.co/re9Wjf19vK

Pfizer's Paxlovid fails as 15-day treatment for long COVID, study finds https://t.co/u3wDGUZL8s https://t.co/H7rNkEGC2s

Pfizer aims to save $1.5 billion by 2027 in first wave of new cost cuts

Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial https://t.co/1HCc8JsuZy https://t.co/bHfQ2WNCOK

Moderna wins case in patent dispute with Pfizer, BioNTech over COVID shot https://t.co/pu0pSdZbog https://t.co/gKLeO9j877

⚠️ JUST IN: *PFIZER SAYS YOUNG BOY WHO GOT GENE THERAPY SUFFERED CARDIAC ARREST $PFE https://t.co/VXFOAflzIJ

Pfizer wants the $75 mln left from SAC Capital’s insider trading settlement with SEC https://t.co/gRRWscbh4s https://t.co/01D983fx9G

Pfizer reports patient death in Duchenne gene therapy study https://t.co/4qCybBOOSL https://t.co/GfgTr3Dxvm

AI-Driven Drug Discovery by Pfizer and Austrian Institute Set to Transform Healthcare

S&amp;P index error may have sparked turbulence in Morgan Stanley, Pfizer shares, traders say https://t.co/bV5U63lZZW https://t.co/lXrxneO76p

Ex-Pfizer employee convicted of insider trading on COVID drug trial https://t.co/luI3r8Ww4b https://t.co/phN98DFyMs

Former Pfizer employee goes down for insider trading in COVID drug trial

Pfizer closes Seagen acquisition

Pfizer shares fall as 2024 revenue and profit forecast disappoints

Seagen gains amid options trades, optimism for FTC approval for Pfizer deal

Pfizer's twice-daily weight loss pill joins a long list of obesity drug flops - CNBC

⚠️BREAKING: *PFIZER SHARES TUMBLE 7% AFTER ABANDONING PLANS FOR WEIGHT LOSS PILL $PFE https://t.co/SrVSxf8PwG

Soalan Lazim

S&P index error may have sparked turbulence in Morgan Stanley, Pfizer shares, traders say https://t.co/bV5U63lZZW https://t.co/lXrxneO76p